Now in its 14th year, the EBG Biosimilars Conference in London has grown steadily and has become the main annual gathering of the world's biosimilars experts. It is the 'not to be missed' biosimilar medicines event if you wish to stay tuned with all market, regulatory and scientific developments.
We encourage real debate amongst all stakeholders on the most relevant biosimilar topics, increased communication and interaction with international key regulators and stakeholders, the leading companies in the biosimilar medicines space and hundreds of delegates from all over the world. We also offer great networking opportunities and welcome you to join this rapidly growing international biosimilar experts' community!
2016 Key Themes:
- Adopting and rolling-out a multi-stakeholder approach in Europe
- Reducing the information gap on biosimilar medicines
- Supporting international regulatory convergence
- Additional Interactive US Master Class
Biologics, Biosimilars & Interchangeable Biologics in a World of Global Product Development - Is the US Different, and if so in What Ways?
Led by Gillian Woollett, MA, DPhil, Senior Vice President Avalere Health - An Inovalon Company